Back

Endothelial nitric oxide synthase Glu298Asp gene polymorphism is an independent risk factor for inducible myocardial ischemia in patients with suspected coronary artery disease

27 August 2016 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Biomarkers in CVD Biomarkers ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Cecilia Vecoli

Institute of Clinical Physiology (IFC), Pisa (Italy)

18 More presentations in this session

Presentation thumbnail
Doctor D. Kimenai (Edinburgh, GB)
Abstract Slides
Presentation thumbnail
Doctor V. Baggen (Rotterdam, NL)
Abstract
Presentation thumbnail
Mr J. Brynildsen (Nordbyhagen, NO)
Abstract Slides
Presentation thumbnail
Professor A. Pereira (Funchal, PT)
Abstract
Presentation thumbnail
Ms N. van der Linden (Maastricht, NL)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1 - Biomarkers in CVD

The Event

Event poster

ESC Congress 2016

27 August 2016 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Glu298Asp variant of endothelial nitric oxide synthase gene and acute or early presentation of coronary artery disease: An updated systematic review and meta-analysis
27 August 2023
thumbnail
Congress Presentation
Endothelial dysfunction evaluation in patients with ischemic heart disease and concomitant gastroesophageal reflux disease
29 June 2021
thumbnail
Congress Presentation
Nitro-oxidative stress impairs single cardiomyocyte adrenergic reserve in a murine model of HFpEF.
27 August 2022
thumbnail
Webinar
Angina/ischaemia with non-obstructive coronary arteries (ANOCA/INOCA)
16 October 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources